Php305 - Considering Children Alongside Adults in Nice Technology Appraisals and Highly Specialised Technologies Evaluations

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1199
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prm184 - Analysis of Utility Values Used in Nice Appraisals of Highly Specialised Technologies

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Prm127 - Economic Modelling Considerations in Rare Diseases: A Targeted Review of Highly Specialised Technology Appraisals

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

PHP151 the Influence of Patient Compliance Arguments in Nice Technology Appraisals

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Utility Values in National Institute for Health and Clinical Excellence (NICE) Technology Appraisals

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Php232 - A Comparison of Cost-Effectiveness Assessments Between Nice and SMC Technology Appraisals

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Life and Death of the End of Life Treatment Appraisal Criteria in Nice Technology Appraisals?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Pmd171 - Health Technology Assessment of Companion Diagnostics Alongside Therapeutc Agents in Oncology: Experience of the Nice Technology Appraisal Programme

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Php295 - Review of Possible Causes of Variation in National Institute for Health and Care Excellence (Nice) Technology Appraisals

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Strimvelis® for Treating Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Evaluation

PharmacoEconomics - Open
Health PolicyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy